Literature DB >> 2452827

Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay.

J P Gregersen1, H Wege, L Preiss, K D Jentsch.   

Abstract

A micromethod for the detection of human immunodeficiency virus (HIV) and other retroviruses in cell culture supernatants is described which applies a DEAE ion exchanger for recovery of polynucleotides synthesized in vitro by the retroviral reverse transcriptase. Cell culture, sample preparation, and test performance including the washing step are adapted to microtitre plates. Compared to the standard method this technique produced less non-specific reactions, resulting in a more than 3-fold higher sensitivity, a higher reproducibility due to lower intrarun variations and allowed an increase in the daily sample accomplishment per person 3- to 4-fold at lower costs per sample.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452827     DOI: 10.1016/0166-0934(88)90159-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Porcine retrovirus: optimal conditions for its biochemical detection.

Authors:  L Phan-Thanh; B Kaeffer; E Bottreau
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  A CD 4: immunoglobulin fusion protein with antiviral effects against HIV.

Authors:  J P Gregersen; S Mehdi; H Gelderblom; G Zettlmeissl
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication.

Authors:  A Baur; T Harrer; M Peukert; G Jahn; J R Kalden; B Fleckenstein
Journal:  Klin Wochenschr       Date:  1991-10-02

4.  An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.

Authors:  D J Hooker; G Tachedjian; A E Solomon; A D Gurusinghe; S Land; C Birch; J L Anderson; B M Roy; E Arnold; N J Deacon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant.

Authors:  D S Threadgill; W K Steagall; M T Flaherty; F J Fuller; S T Perry; K E Rushlow; S F Le Grice; S L Payne
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

Authors:  R Wagner; H Fliessbach; G Wanner; M Motz; M Niedrig; G Deby; A von Brunn; H Wolf
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.

Authors:  R Wagner; S Modrow; T Böltz; H Fliessbach; M Niedrig; A von Brunn; H Wolf
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.

Authors:  C A Van Baalen; M Schutten; R C Huisman; P H Boers; R A Gruters; A D Osterhaus
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat.

Authors:  K H Siebelink; I H Chu; G F Rimmelzwaan; K Weijer; A D Osterhaus; M L Bosch
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.